Join us as we hear from Jim Minow, Dr. Andrew Heaton, and Shannon Malloy as we start a new year; a brighter future emerges for Cure JM, thanks to the unwavering dedication of our incredible community. Your extraordinary commitment to funding groundbreaking research continues to drive us forward. Gather with us in celebrating the strides we’ve made together and explore the remarkable impact of your support. Together, we’ll set our sights on even more remarkable achievements in the coming year. Here’s to a future filled with hope, progress, and continued success toward better treatments and a cure.
Abatacept Trial Concludes With Favorable Results In JM Treatment
A clinical trial treating patients with juvenile myositis with the drug abatacept resulted in lower disease activity and clinically significant responses in most patients. The
